Gelteq (GELS) Institutional Ownership $1.92 0.00 (0.00%) As of 02/21/2025 03:59 PM Eastern Add Compare Share Share Ownership Stock AnalysisChartCompetitorsFinancialsOwnershipSEC FilingsTrends Institutional Ownership Changes (13F Filings) for Gelteq (NASDAQ:GELS)Number ofInstitutional Buyers(last 12 months)1TotalInstitutional Inflows(last 12 months)$55.10KNumber ofInstitutional Sellers(last 12 months)0 Get GELS Insider Trade Alerts Want to know when executives and insiders are buying or selling Gelteq stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address Gelteq Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails2/17/2025 Citadel Advisors LLC23,748$55K0.0%N/A0.252% (Data available from 1/1/2016 forward) GELS Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of GELS shares? During the previous two years, the following institutional investors and hedge funds held shares of Gelteq shares: Citadel Advisors LLC ($55K).Learn more on GELS's institutional investors. Which institutional investors have been buying Gelteq stock? The following institutional investors have purchased Gelteq stock in the last 24 months: Citadel Advisors LLC ($23.75K). How much institutional buying is happening at Gelteq? Institutional investors have bought a total of 23,748 shares in the last 24 months. This purchase volume represents approximately $55.10K in transactions. Related Companies Acumen Pharmaceuticals Institutional Ownership Cellectis Institutional Ownership Scilex Institutional Ownership Galectin Therapeutics Institutional Ownership IGM Biosciences Institutional Ownership X4 Pharmaceuticals Institutional Ownership Avalo Therapeutics Institutional Ownership Mersana Therapeutics Institutional Ownership Tiziana Life Sciences Institutional Ownership I-Mab Institutional Ownership This page (NASDAQ:GELS) was last updated on 2/22/2025 by MarketBeat.com Staff From Our PartnersElon’s “New Gold”MIT scientists just developed a brand-new metal… A metal that’s shaping up to be, not only the biggest brea...True Market Insiders | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredThe Real Hillbilly ElegyThe mountains of Appalachia are incredible to behold. Spanning thousands of miles across Alabama, Kentucky...Porter & Company | SponsoredBuy this AI Stock Before Elon’s AnnouncementWith Trump back in office, xAI is primed to become the leader in generative AI, leaving competitors in the dus...InvestorPlace | SponsoredElon Social Security shock?“A Maniacal Sense of Urgency” We could be just days away from Elon Musk launching his next big venture. One...Altimetry | SponsoredMajor AI announcement for 2025BIG NEWS: “Market Wizard” Larry Benedict Releases a Whole New Way to Trade AI StocksBrownstone Research | SponsoredThree new patents reveal Elon and Trump’s secret “Project America”Right now for a limited time… You can get Tim Bohen’s top 5 Trump stocks for 2025… For only ONE DOLLAR!...Timothy Sykes | Sponsored(1) Elon Musk’s Final Project REVEALEDThe world’s richest man has an ace up his sleeve. You see, while everyone is talking about Elon Musk’s plan...Paradigm Press | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Gelteq Limited Please log in to your account or sign up in order to add this asset to your watchlist. Share Gelteq With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
